CURA:CC News and Press, Cura:Cc From 10/05/22

Curaleaf to Report Third Quarter 2022 Financial and Operational Results PR Newswire WAKEFIELD, Mass. , Oct. 5, 2022 /PRNewswire/ -- Curaleaf Holdings, Inc. (CSE: CURA / OTCQX: CURLF) ("Curaleaf" or the "Company") , a leading international provider of ...

Curaleaf Completes Acquisition of Tryke Companies PR Newswire Bolsters Company's Presence in Three Key Growth Markets of Arizona , Nevada and Utah Expands Curaleaf's Operations to 29 Cultivation Sites and 144 Dispensaries Nationwide WAKEFI...

Investing in U.S. stocks provides several advantages to Canadians. Investors shopping south of the border can diversify their portfolio while gaining access to the largest economy in the world. Some of these companies sell their products and services all around the world, allowing them to e...

Curaleaf Completes Majority Stake Acquisition of Germany's Four 20 Pharma PR Newswire Deal Solidifies Curaleaf's Strategic Advantage in Germany as the Country Prepares for Adult-Use WAKEFIELD, Mass. , Sept. 19, 2022 /PRNewswire/ -- Curaleaf ...

Curaleaf Celebrates Opening of Allentown, Pennsylvania Dispensary Canada NewsWire Curaleaf's retail presence grows to 18 locations in Pennsylvania and 137 nationwide WAKEFIELD, Mass. , Sept. 19, 2022 /CNW/ -- Curaleaf Holdings, Inc. (C...

Curaleaf Annual Meeting of Shareholders Reminder PR Newswire Shareholders are reminded to vote their shares prior to the proxy voting deadline of 2:00 p.m. (Eastern Time) on September 6, 2022 WAKEFIELD, Mass. , Sept. 1, 2022 /PRNewswi...

Latest Move Marks Continued Expansion of European Footprint in Growing Medical Cannabis Market Curaleaf International (the “Company”) part of Curaleaf Holdings (CNSX:CURA), Europe’s largest vertically integrated cannabis company, is pleased to announce t...

Curaleaf Announces Majority Stake and Forms Strategic Partnership with Germany's Four 20 Pharma, a Fully EU-GMP & GDP Licensed Producer and Distributor of Medical Cannabis Curaleaf Announces Majority Stake and Forms Strategic Partnership with Germany's Four 20 Pharma, a Full...

Curaleaf Reports Second Quarter 2022 Results PR Newswire Second Quarter 2022 Revenue of $338 Million , an increase of 8% sequentially and YoY Second Quarter 2022 Adjusted EBITDA (1) of $86 Million , an increase of 18% sequentially and 2% YoY ...

Curaleaf Bolsters Executive Leadership Team with Three Key Hires Canada NewsWire Ed Kremer Joins as Chief Financial Officer, Camilo Lyon is Named Chief Investment Officer and Mitch Hara Fills New Role of Chief Strategy Officer WAKEFIELD, Mass. , A...